Interestingly, when the response of SCID-hu mice to TACI-Fc treatment was correlated with TACI expression levels in the myeloma cells, it was found that the response to TACI-Fc was superior in TACIhigh myeloma cells compared with TACIlow cells. The gene discussed is TNFRSF13B; the disease is plasma cell myeloma.